ImmunoGen
IMGN
#2162
Rank
NZ$14.91 B
Marketcap
NZ$53.41
Share price
0.00%
Change (1 day)
133.19%
Change (1 year)

Earnings for ImmunoGen (IMGN)

Earnings in 2023 (TTM): -NZ$96.61 Million

According to ImmunoGen 's latest financial reports the company's current earnings are NZ$0.28 Billion. In 2022 the company made an earning of -NZ$0.38 Billion a decrease over its 2021 earnings that were of -NZ$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunoGen from 1989 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$96.61 Million-74.03%
2022 -NZ$0.38 Billion72.45%
2021 -NZ$0.22 Billion495.9%
2020 -NZ$36.21 Million-75.71%
2019 -NZ$0.15 Billion-44.88%
2018 -NZ$0.28 Billion99.42%
2017 -NZ$0.14 Billion
2015 -NZ$0.18 Billion43.7%
2014 -NZ$0.13 Billion135.39%
2013 -NZ$52.74 Million-66.03%
2012 -NZ$0.16 Billion42.86%
2011 -NZ$0.11 Billion16.68%
2010 -NZ$93.13 Million32.83%
2009 -NZ$70.12 Million-1.99%
2008 -NZ$71.54 Million108.61%
2007 -NZ$34.3 Million-10.13%
2006 -NZ$38.16 Million28.86%
2005 -NZ$29.62 Million120.33%
2004 -NZ$13.45 Million-61.19%
2003 -NZ$34.63 Million-16.6%
2002 -NZ$41.53 Million51.86%
2001 -NZ$27.35 Million
1999 NZ$1.53 M-112.68%
1998 -NZ$12.15 Million-13.41%
1997 -NZ$14.03 Million-10.87%
1996 -NZ$15.74 Million-35.66%
1995 -NZ$24.46 Million-19.21%
1994 -NZ$30.27 Million-14.49%
1993 -NZ$35.4 Million23.95%
1992 -NZ$28.56 Million
1989 -NZ$11.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$55.40 B-51,703.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.96 B-26,146.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$20.26 B-18,978.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.48 B-35,945.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.09 B-13,231.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.56 B-14,595.71%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$13.73 B-12,895.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.36 Billion 1,159.30%๐Ÿ‡บ๐Ÿ‡ธ USA